Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A

Rio de Janeiro 20241-180

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling